CNBX PHARMACEUTICALS INC. Other Comprehensive Income (Loss), before Tax
CNBX PHARMACEUTICALS INC. (CNBX) reported Other Comprehensive Income (Loss), before Tax of $42.26 thousand for the 3-month period ending 2022-05-31, per its 10-Q filed 2022-07-14.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossBeforeTax · last filed 2022-07-14
- CNBX PHARMACEUTICALS INC. other comprehensive income (loss), before tax for the quarter ending 2022-05-31 was $42.26K.
- CNBX PHARMACEUTICALS INC. other comprehensive income (loss), before tax for the quarter ending 2022-02-28 was -$366.79K, a 113.99% decline year-over-year.
- CNBX PHARMACEUTICALS INC. other comprehensive income (loss), before tax for the quarter ending 2021-11-30 was -$281.21K, a 348.67% decline year-over-year.
- CNBX PHARMACEUTICALS INC. other comprehensive income (loss), before tax for the quarter ending 2021-05-31 was -$1.73M, a 2366.83% decline year-over-year.
| Period end | Other Comprehensive Income (Loss), before Tax 3 month | Other Comprehensive Income (Loss), before Tax 6 month | Other Comprehensive Income (Loss), before Tax 9 month |
|---|---|---|---|
| 2022-05-31 | $42.26K 10-Q · filed 2022-07-14 | -$324.53K derived: sum of 2 quarters · filed 2022-07-14 | -$605.74K 10-Q · filed 2022-07-14 |
| 2022-02-28 | -$366.79K 10-Q · filed 2022-04-12 | -$648.00K 10-Q · filed 2022-04-12 | |
| 2021-11-30 | -$281.21K 10-Q · filed 2022-01-13 | ||
| 2021-05-31 | -$1.73M 10-Q · filed 2022-07-14 | $891.55K derived: sum of 2 quarters · filed 2022-07-14 | $1.00M 10-Q · filed 2022-07-14 |
| 2021-02-28 | $2.62M 10-Q · filed 2022-04-12 | $2.74M 10-Q · filed 2022-04-12 | |
| 2020-11-30 | $113.09K 10-Q · filed 2022-01-13 | ||
| 2020-05-31 | $76.34K 10-Q · filed 2021-07-14 | -$2.07M derived: sum of 2 quarters · filed 2021-07-14 | -$5.58M 10-Q · filed 2021-07-14 |
| 2020-02-29 | -$2.14M 10-Q · filed 2021-04-14 | -$5.65M 10-Q · filed 2021-04-14 |